0001127602-15-025709.txt : 20150824
0001127602-15-025709.hdr.sgml : 20150824
20150824182228
ACCESSION NUMBER: 0001127602-15-025709
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150824
FILED AS OF DATE: 20150824
DATE AS OF CHANGE: 20150824
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alkermes plc.
CENTRAL INDEX KEY: 0001520262
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981007018
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
BUSINESS PHONE: 00-353-1-772-8000
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC
DATE OF NAME CHANGE: 20110804
FORMER COMPANY:
FORMER CONFORMED NAME: Antler Science Two Ltd
DATE OF NAME CHANGE: 20110509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cooke Shane
CENTRAL INDEX KEY: 0001524823
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35299
FILM NUMBER: 151071853
MAIL ADDRESS:
STREET 1: TREASURY BUILDING LOWER GRAND CANAL ST.
CITY: DUBLIN 2
STATE: L2
ZIP: 00000
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2015-08-24
0001520262
Alkermes plc.
ALKS
0001524823
Cooke Shane
CONNAUGHT HOUSE
1 BURLINGTON ROAD
DUBLIN 4 IRELAND
1
President, Alkermes plc
Ordinary Shares
2015-08-24
4
M
0
18000
14.60
A
58640
D
Ordinary Shares
2015-08-24
4
S
0
1000
53.395
D
57640
D
Ordinary Shares
2015-08-24
4
S
0
1200
54.6522
D
56440
D
Ordinary Shares
2015-08-24
4
S
0
2500
56.6747
D
53940
D
Ordinary Shares
2015-08-24
4
S
0
5661
57.7769
D
48279
D
Ordinary Shares
2015-08-24
4
S
0
5107
58.6363
D
43172
D
Ordinary Shares
2015-08-24
4
S
0
2532
59.4083
D
40640
D
Employee Stock Option (Right to Buy)
14.60
2015-08-24
4
M
0
18000
0
D
2021-10-05
Ordinary Shares
18000
106000
D
This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.05 to $53.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.28 to $55.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $56.01 to $57.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.04 to $58.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.05 to $59.02. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $59.0675 to $59.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The option becomes exercisable in equal annual installments over a four year period, at the rate of 25% per year commencing on 10/5/12.
/s/ Jennifer Baptiste, attorney-in-fact for Shane Cooke
2015-08-24